-
MIRA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
MIRA Pharmaceuticals (MIRA)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 3 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 20.04 mm |
Total shares | 3.86 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Bay Shore Trust | 3.86 mm | $16.79 mm |
Sandy Spring Bank | 675.00 | $3.14 mm |
UBS UBS | 25.00 | $116.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Dec 24 | Edward Clouston MacPherson | Stock Options Common Stock | Grant | Acquire A | No | No | 1.19 | 25,000 | 29.75 k | 25,000 |
9 Dec 24 | Michelle Yanez | Stock Options Common Stock | Grant | Acquire A | No | No | 1.19 | 150,000 | 178.50 k | 150,000 |
9 Dec 24 | Erez Aminov | RSU Common Stock | Grant | Acquire A | No | No | 0 | 500,000 | 0.00 | 500,000 |
9 Dec 24 | Erez Aminov | Stock Options Common Stock | Grant | Acquire A | No | No | 1.19 | 2,000,000 | 2.38 mm | 2,000,000 |
9 Dec 24 | Denil Nanji Shekhat | Stock Options Common Stock | Grant | Acquire A | No | No | 1.19 | 50,000 | 59.50 k | 50,000 |
9 Dec 24 | Giudice Matthew Paul Del | Stock Options Common Stock | Grant | Acquire A | No | No | 1.19 | 25,000 | 29.75 k | 75,000 |